Tolebrutinib had the most protective effect against disability worsening at 6 months in patients with multiple sclerosis who ...

High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...

Data show minimal risk of stopping DMTs in older MS patients with stable disease. Now, the focus has shifted to understanding ...

The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

Ocrevus treatment was linked to increases in myelin and reductions in iron in MS patients with paramagnetic rim lesions, per ...

Proposed McDonald criteria revisions could help diagnose MS patients who would have been missed with earlier versions, an ...

Opens in a new tab or window High-dose vitamin D reduced disease activity in early MS and CIS compared with ... defined as occurrence of a relapse and/or MRI activity over 24 months of follow ...

Ocrelizumab treatment in Black and Hispanic patients with MS reduces NfL levels and prevents the forming of contrast-enhancing lesions and new or enlarging T2 lesions.